Pier Capital, LLC Guardant Health, Inc. Transaction History

Pier Capital, LLC

$670 Million
Q3 2024

A detailed history of Pier Capital, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pier Capital, LLC holds 158,429 shares of GH stock, worth $5.56 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

158,429

Previous 115,854 36.75%

Holding current value

$5.56 Million

Previous $3.35 Million 8.58%

% of portfolio

0.54%

Previous 0.52%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$22.3 - $36.29 $949,422 - $1.55 Million	42,575 Added 36.75%	158,429 $3.63 Million
Q2 2024 Aug 07, 2024	BUY	$16.07 - $31.84 $1.86 Million - $3.69 Million	115,854 New	115,854 $3.35 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $4.54 Million - $6.17 Million	-45,416 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $58,874 - $81,949	-733 Reduced 1.59%	45,416 $5.08 Million
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $1.07 Million - $1.72 Million	-17,656 Reduced 27.67%	46,149 $3.74 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $950,721 - $1.43 Million	16,103 Added 33.76%	63,805 $4.44 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $1.33 Million - $1.85 Million	-22,360 Reduced 31.91%	47,702 $3.73 Million
Q3 2019 Nov 13, 2019	SELL	$62.59 - $110.3 $404,018 - $711,986	-6,455 Reduced 8.44%	70,062 $4.47 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $1.75 Million - $2.49 Million	27,323 Added 55.54%	76,517 $6.61 Million
Q1 2019 Apr 24, 2019	SELL	$34.3 - $97.98 $2.92 Million - $8.33 Million	-84,999 Reduced 63.34%	49,194 $3.77 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $3.92 Million - $6.19 Million	134,193 New	134,193 $5.04 Million

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Account